Page 3695 - Week 10 - Thursday, 19 September 2019

Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Debates(HTML) . . . . PDF . . . . Video


b) Accepted – On completion of the approval of the governance through PAC, all procurement activities are to be notified to Health Procurement where this recommendation can be met.

c) Accepted.

(f) All four recommendations are complete.

(g) All recommendations were accepted.

Canberra Health Services

(a) Senior Medical Officer Attendance Management.

(b) Protiviti Pty Ltd.

(c) The work is ongoing therefore is yet to be fully costed.

(d) (i) The audit report is still in draft and therefore findings are not finalised.

(ii) The audit report is still in draft and therefore recommendations are not finalised.

(e) Canberra Health Services management has provided advice to Executive. Executive will be considering the advice shortly.

(f) Refer to the response to (2) (d) (i).

(g) Refer to the response to (2) (d) (i).

(3)

ACT Health Directorate

(a) (i), (ii) & (iii) No briefings have been provided to the relevant minister, ACT Health Directorate Director-General or the Canberra Health Services CEO.

(b) Not applicable. Refer to the response to (3) (a) (i), (ii) & (iii).

Canberra Health Services

(a) (i), (ii) & (iii) Internal Audits are part of a directorate’s business as usual, and resulting recommendations are managed by the directorate as part of overall governance. As the current Internal Audit has yet to be finalised there are no recommendations or advice to progress.

(b) Not applicable. Refer to the response to (3) (a) (i), (ii) & (iii).

Health—infectious diseases project
(Question No 2590)

Mrs Dunne asked the Minister for Health, upon notice, on 2 August 2019:

(1) In relation to Estimates question on notice No E19-265, which budget year originally allocated $398 000 for the Protecting Canberrans from Infectious Diseases project (“the project”).

(2) What was the (a) original scope and (b) anticipated outcomes, of the project.

(3) Why did the ACT Pathology Laboratory Information System, due for completion by June 2021, defer the tendering process for the project until the latter half of 2018-19.

(4) To what extent and in what ways has the deferred completion date changed the (a) scope and (b) anticipated outcomes, of the project.


Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Debates(HTML) . . . . PDF . . . . Video